NewsRoom Articles

WednesdayJul 15, 2026 10:00 am

Backlash Prompts Meta to Take Down its AI Image Generation Feature

Meta has removed its newly launched Muse Image tool after facing widespread backlash over privacy concerns and automatic enrollment of public account users. The feature enrolled all public-facing profile users by default unless they manually disabled it in settings. Creators, privacy advocates, and industry representatives quickly objected to the default opt-out structure, arguing that it violated established user consent principles and likeness rights protections. Within days of release, Meta removed the feature entirely, acknowledging in a statement that it had "missed the mark" on implementation and user expectations. Meta's Muse Image represented the company's initial entry into AI-generated imagery, accessible through the Meta AI chatbot interface. The tool synthesized…

MondayJul 13, 2026 10:00 am

Widely Prescribed Thyroid Hormone Could Prevent Pediatric Brain Tumor Recurrence

A research team investigating children's brain tumors has found promising results combining a hormone treatment with standard chemotherapy protocols. Triiodothyronine, commonly called T3, is a medication long used to manage thyroid disorders in patients throughout the lifespan. The hormone showed enhanced effectiveness when added to conventional cancer therapy in laboratory studies and animal models. A clinical trial is now recruiting pediatric patients to test whether this combined approach works in actual clinical settings. Medulloblastoma accounts for the leading category of malignant pediatric brain cancers, striking hundreds of young children annually. Treatment currently requires aggressive intervention that combines surgical removal with systemic therapy and radiation.…

WednesdayJul 08, 2026 10:00 am

AI Tool Predicts the Optimal Presurgical Treatments for Breast Cancer

A new AI tool developed at Cedars-Sinai could change how doctors pick the most suitable presurgical therapy for breast cancer patients. The tool, called BRIDGE, was detailed in Annals of Oncology alongside early validation data. It reads genetic signals inside a tumor to identify which subtypes are present, rather than forcing the whole mass into one category. Treatment decisions for patients with breast cancer depend on how each tumor is classified and labeled. Doctors sort masses into groups like triple-negative or HER2-positive, then select from chemotherapy, targeted therapy, or immunotherapy given before the operation. When that approach works, a patient…

ThursdayJul 02, 2026 9:45 am

Frontieras North America Inc. Advances Coal Innovation Amid New Federal Investment

A newly released federal funding package is designed to support coal-fired power generation, coal exports and new coal infrastructure projects across the United States. Frontieras North America is commercializing its patented FASForm(TM) Solid Carbon Fractionation technology, which separates coal into multiple valuable outputs through a continuous-feed process. Frontieras is also currently advancing the first commercial-scale deployment of the technology in Mason County, West Virginia. The Trump administration’s announcement earlier this month of nearly $700 million in new federal support for the U.S. coal industry has renewed attention on coal’s role in the nation’s energy and industrial future. Among the companies operating in…

WednesdayJul 01, 2026 10:00 am

Asia’s Imports of Thermal Coal Ramp Up Amid Energy Supply Disruptions

Thermal coal consumption across Asia is accelerating following energy market disruptions triggered by geopolitical instability centered in the Middle East. Regional seaborne import volumes for June are forecast to reach their highest level in six months at 77.37 million tons, with growth notably driven by Japan and South Korea. The two Asian countries were more capable of rapidly switching between coal and liquefied natural gas based on price signals and supply availability than their neighbors. This regional acceleration stems from geopolitical shocks that dramatically reshaped energy economics throughout Asia. American military attacks on Iran prompted Tehran to restrict shipping through…

MondayJun 29, 2026 10:00 am

Trump Signs Executive Orders Backing Quantum Computing

Quantum computing advancement has become a defining priority for American national security and technological competitiveness. The Trump administration released executive orders addressing two interconnected objectives: accelerating domestic quantum research and protecting federal computing infrastructure from emerging threats. Administration officials project that a functional quantum computer could exist by 2028. Michael Kratsios, the president's chief science adviser, stated that this timeline represents a realistic but demanding goal. Geopolitical competition with China motivated immediate federal action, reflecting concerns that American technological leadership requires quantum capability development. Quantum machines operate according to principles that are fundamentally different from traditional computing architecture. Rather than transistor-based binary processing, quantum systems harness superposition and entanglement. These principles…

WednesdayJun 24, 2026 10:00 am

Scientists Find Targeting Enzyme That Could Block Brain Metastases

Researchers from King's College London and McMaster University have made a discovery that could fundamentally change how doctors treat brain cancer. The team identified a molecular pathway that appears critical to cancer's ability to migrate to the brain. Working with a commercial partner called Block Biosciences, they created drug candidates designed to block this process. This work represents a shift from treating cancer after it spreads to preventing that spread in the first place. The enzyme, IMPDH2, which appears in two separate versions within human cells, emerged as the key target for intervention. Only one version plays a role in…

WednesdayJun 17, 2026 10:00 am

Biomarkers Could Predict Patients’ Response to Bladder Cancer Therapy

Researchers at Northwestern Medicine have identified immune system markers that may help predict who responds to BCG bladder cancer therapy and who does not. The Journal of Clinical Investigation published the findings. The study centers on Bacillus Calmette-Guérin (BCG) for non-muscle-invasive bladder cancer, a cancer affecting the bladder lining, and why the therapy fails for some patients. What determines whether BCG succeeds or fails for any given patient has never been fully explained. BCG functions by exposing the body to a weakened form of bacteria, triggering the immune system to mount a response. Despite its long history as a front-line treatment, researchers have remained uncertain about why some patients benefit significantly while others do not.…

TuesdayJun 16, 2026 9:00 am

Frontieras North America Inc. Unlocks the Untapped Value of America’s Coal Reserves

Despite decades of energy innovation, coal remains one of the largest and most accessible energy resources in the world. Frontieras’s position is straightforward: Coal is not obsolete; it is underutilized. FASForm(TM) thermally fractionates coal into multiple commercial outputs, including diesel, jet fuel, naphtha, hydrogen, purified industrial carbon and fertilizer-related products. Coal has powered economies, industries and infrastructure for generations, yet much of its potential remains untapped. Frontieras North America is advancing a new approach to coal utilization through its proprietary FASForm platform, a patented process that converts coal into fuels, hydrogen and industrial materials, positioning one of America’s most abundant resources as a…

MondayJun 15, 2026 10:00 am

IEA Warns That Coal Investment Has Reached 14-Year Record

Coal investment has climbed to levels unseen since the early 2010s, a troubling reversal for climate advocates worldwide. The International Energy Agency projects spending will hit $180 billion by the end of 2026, representing a 4% jump from 2025 investment levels. This suggests fossil fuels remain deeply entrenched in global energy strategies despite renewable energy's rapid expansion. China and India dominate this spending surge in ways that reshape the global energy landscape. China alone accounts for more than two-thirds of worldwide coal investment, with steam coal production funding alone approaching $100 billion annually, roughly double what was spent a decade ago. India is the second major investor, having tripled coal spending over the past 10 years…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000